DK10288A - Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli - Google Patents

Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli

Info

Publication number
DK10288A
DK10288A DK010288A DK10288A DK10288A DK 10288 A DK10288 A DK 10288A DK 010288 A DK010288 A DK 010288A DK 10288 A DK10288 A DK 10288A DK 10288 A DK10288 A DK 10288A
Authority
DK
Denmark
Prior art keywords
invaccine
recombinated
falciparum
coli
isolating
Prior art date
Application number
DK010288A
Other languages
English (en)
Other versions
DK10288D0 (da
Inventor
Peter Arletti Dephillips
Gail Marie Folena Wasserman
Robert David Sitrin
Dane William Zabriskie
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK10288D0 publication Critical patent/DK10288D0/da
Publication of DK10288A publication Critical patent/DK10288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK010288A 1986-05-12 1988-01-11 Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli DK10288A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86181086A 1986-05-12 1986-05-12
PCT/US1987/001115 WO1987006939A1 (en) 1986-05-12 1987-05-11 Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli

Publications (2)

Publication Number Publication Date
DK10288D0 DK10288D0 (da) 1988-01-11
DK10288A true DK10288A (da) 1988-01-11

Family

ID=25336830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK010288A DK10288A (da) 1986-05-12 1988-01-11 Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli

Country Status (8)

Country Link
EP (1) EP0252588A3 (da)
JP (1) JPH01502556A (da)
AU (1) AU603586B2 (da)
DK (1) DK10288A (da)
FI (1) FI885237A0 (da)
PT (1) PT84850B (da)
WO (1) WO1987006939A1 (da)
ZA (1) ZA873338B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289129A3 (en) * 1987-03-26 1990-10-10 Repligen Corporation High purity protein a preparation
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US6093406A (en) * 1988-06-02 2000-07-25 The United States Of America As Represented By The Secretary Of The Army Vaccine for induction of immunity to malaria
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
DE69124561T2 (de) * 1990-03-30 1997-09-04 Shiseido Co. Ltd., Tokio/Tokyo Methode zur reinigung von polypeptiden
CA2497209C (en) * 2002-09-06 2015-04-28 Genentech, Inc. Process for protein extraction
ATE514774T1 (de) * 2004-04-02 2011-07-15 Hoffmann La Roche Hoch aufgereinigte proteinase k
WO2008122089A1 (en) * 2007-04-05 2008-10-16 The University Of Queensland Method of purifying recombinant peptides by selective precipitation
US9115205B2 (en) 2010-10-18 2015-08-25 The United States Of America, As Represented By The Secretary Of The Army Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
EP3374376B1 (en) * 2015-11-09 2020-03-18 Biological E Limited Industrially scalable process for recovering biologically active recombinant carrier proteins
AU2018268305B2 (en) 2017-05-15 2022-10-06 C-Lecta Gmbh Enzyme products
CN114630584A (zh) * 2019-11-07 2022-06-14 纽崔西亚公司 具有致耐受性肽的深度乳清蛋白水解产物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
DE3583347D1 (de) * 1984-02-22 1991-08-08 Wellcome Found Klonieren von dna fuer protozoenantigene.
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
EP0192626B1 (en) * 1985-02-07 1992-07-29 Smithkline Beecham Corporation Malaria vaccine
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法

Also Published As

Publication number Publication date
PT84850B (pt) 1990-02-08
EP0252588A2 (en) 1988-01-13
FI885237L (fi) 1988-11-11
FI885237A7 (fi) 1988-11-11
WO1987006939A1 (en) 1987-11-19
DK10288D0 (da) 1988-01-11
JPH01502556A (ja) 1989-09-07
FI885237A0 (fi) 1988-11-11
ZA873338B (en) 1988-07-27
EP0252588A3 (en) 1989-07-12
AU7440087A (en) 1987-12-01
AU603586B2 (en) 1990-11-22
PT84850A (en) 1987-06-01

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO871547L (no) Hurtigkopling for roer og lignende.
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
FI874819L (fi) Human rekombinant endotelcell vaextfaktor.
DE3786767D1 (de) Neues polypeptid.
NO163962C (no) Flytende vaskemiddel og fremgangsmaate for fremstilling avdette.
NO871409D0 (no) Fusjonsprotein.
DK122687D0 (da) Polypeptid, dna og anvendelse deraf
DK10288A (da) Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli
NO882917D0 (no) Fusjonsproteiner og partikler.
FI874055A0 (fi) Protein med antikoagulanta och antimetastatiska egenskaper.
DK425687D0 (da) Fremgangsmaade og saet til rensning af kontaktlinser
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
NO870965L (no) Aminosukkerkarboneringsmidler og deres fremstilling.
NO165421C (no) Fremgangsmaate og anordning for avskinning.
DK466688D0 (da) Kontaktlinserensemiddel og fremgangsmaade til dets anvendelse
DE3853743D1 (de) Rekombinanter menschlicher ADF.
DK506487A (da) Middel og fremgangsmaade til rensning af levnedsmidler
DK354087D0 (da) Fremgangsmaade til fremme af smaagrises vaekst
DE68917536D1 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.
NO872374D0 (no) Varmepumpe og fremgangsmaate for varmepumpe.
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO880080L (no) Fremgangsmaate for isolering og rensing av p.faliciparum cs-proteinvaksine uttrykt i rekombinant e.coli.
DK165475C (da) Fremgangsmaade og anlaeg til behandling eller undersoegelse af slagtekroppe
NO883772D0 (no) Kontaktlinserensemiddel og anvendelsesmetode.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment